ArticleBioengineering & translational medicine2018

RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors.

Erik C Dreaden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.